Placental Endoplasmic Reticulum Stress and Oxidative Stress in the Pathophysiology of Unexplained Intrauterine Growth Restriction and Early Onset Preeclampsia

Placenta

Volumn 30, Issue SUPPL., 2009, Pages 43-48

  Burton, G J ^a   Yung, H W ^a   Cindrova Davies, T ^a   Charnock Jones, D S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endoplasmic reticulum stress; Intrauterine growth restriction; Oxidative stress; Placental pathology; Preeclampsia

Indexed keywords

CYTOKINE; GLUTAREDOXIN;

ARTICLE; ENDOPLASMIC RETICULUM STRESS; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; TROPHOBLAST;

ENDOPLASMIC RETICULUM; FEMALE; FETAL GROWTH RETARDATION; HUMANS; OXIDATIVE STRESS; PLACENTAL INSUFFICIENCY; PRE-ECLAMPSIA; PREGNANCY; PROTEIN FOLDING; SIGNAL TRANSDUCTION; UTERUS;

EID: 60249089720     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.11.003     Document Type: Article

References (57)

1. Ness R.B., and Sibai B.M. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 195 (2006) 40-49
2. Brosens I., Dixon H.G., and Robertson W.B. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 84 (1977) 656-663
3. Gerretsen G., Huisjes H.J., and Elema J.D. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 88 (1981) 876-881
4. Meekins J.W., Pijnenborg R., Hanssens M., McFadyen I.R., and Van Assche F.A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 101 (1994) 669-674
5. Lyall F. The human placental bed revisited. Placenta 23 (2002) 555-562
6. Khong T.Y., De Wolf F., Robertson W.B., and Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93 (1986) 1049-1059
7. Harris J.W.S., and Ramsey E.M. The morphology of human uteroplacental vasculature. Contrib Embryol 38 (1966) 43-58
8. Bartelmez G.W. The form and functions of the uterine blood vessels in the rhesus monkey. Contrib Embryol 36 (1957) 153-182
9. Brosens J.J., Pijnenborg R., and Brosens I.A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies. Am J Obstet Gynecol 187 (2002) 1416-1423
10. Burton G.J., and Hung T.-H. Hypoxia-reoxygenation: a potential source of placental oxidative stress in normal pregnancy and preeclampsia. Fetal Mat Med Rev 14 (2003) 97-117
11. Hung T.H., Skepper J.N., and Burton G.J. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 159 (2001) 1031-1043
12. Brosens I. A study of the spiral arteries of the decidua basalis in normotensive and hypertensive pregnancies. J Obstet Gynaecol Br Cwlth 71 (1964) 222-230
13. Sheppard B.L., and Bonnar J. The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation. Br J Obstet Gynaecol 83 (1976) 948-959
14. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqeel H., et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. Am J Obstet Gynecol 194 (2006) 921-931
15. Mayhew T.M., Manwani R., Ohadike C., Wijesekara J., and Baker P.N. The placenta in pre-eclampsia and intrauterine growth restriction: studies on exchange surface areas, diffusion distances and villous membrane diffusive conductances. Placenta 28 (2007) 233-238
16. Wang Y., and Walsh S.W. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta 19 (1998) 581-586
17. Hung T.-H., Skepper J.N., Charnock-Jones D.S., and Burton G.J. Hypoxia/reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90 (2002) 1274-1281
18. Soleymanlou N., Wu Y., Wang J.X., Todros T., Ietta F., Jurisicova A., et al. A novel Mtd splice isoform is responsible for trophoblast cell death in pre-eclampsia. Cell Death Differ 12 (2005) 441-452
19. Xu C., Bailly-Maitre B., and Reed J.C. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115 (2005) 2656-2664
20. Cullinan S.B., and Diehl J.A. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int J Biochem Cell Biol 38 (2006) 317-332
21. Yoshida H. ER stress and diseases. FEBS J 274 (2007) 630-658
22. DeGracia D.J., and Montie H.L. Cerebral ischemia and the unfolded protein response. J Neurochem 91 (2004) 1-8
23. Cindrova-Davies T., Spasic-Boskovic O., Jauniaux E., Charnock-Jones D.S., and Burton G.J. Nuclear factor-kappa B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am J Pathol 170 (2007) 1511-1520
24. Yung H.W., Calabrese S., Hynx D., Hemmings B.A., Cetin I., Charnock-Jones D.S., et al. Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol 173 (2008) 451-462
25. Brewer J.W., Hendershot L.M., Sherr C.J., and Diehl J.A. Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression. Proc Natl Acad Sci U S A 96 (1999) 8505-8510
26. Widdows K., Drewlo S., Baczyk D., Kingdom J., and Ansari T. Stereological evidence for reduced cytotrophoblast proliferation in severe IUGR. Placenta 29 (2008) A.99
27. Yang Z.Z., Tschopp O., Hemmings-Mieszczak M., Feng J., Brodbeck D., Perentes E., et al. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278 (2003) 32124-32131
28. Leung D.N., Smith S.C., To K.F., Sahota D.S., and Baker P.N. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 184 (2001) 1249-1250
29. Smith S.C., Baker P.N., and Symonds E.M. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 177 (1997) 1395-1401
30. Allaire A.D., Ballenger K.A., Wells S.R., McMahon M.J., and Lessey B.A. Placental apoptosis in preeclampsia. Obstet Gynecol 96 (2000) 271-276
31. Ishihara N., Matsuo H., Murakoshi H., Laoag-Fernandez J., Samoto T., and Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186 (2002) 158-166
32. Goswami D., Tannetta D.S., Magee L.A., Fuchisawa A., Redman C.W., Sargent I.L., et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27 (2006) 56-61
33. Redman C.W.G., and Sargent I.L. Placental debris, oxidative stress and pre-eclampsia. Placenta 21 (2000) 597-602
34. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine (1999), Oxford Science Publications, Oxford p. 936
35. Many A., Hubel C.A., and Roberts J.M. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 174 (1996) 288-291
36. Tu B.P., and Weissman J.S. Oxidative protein folding in eukaryotes: mechanisms and consequences. J Cell Biol 164 (2004) 341-346
37. Zhang K., and Kaufman R.J. From endoplasmic-reticulum stress to the inflammatory response. Nature 454 (2008) 455-462
38. Hung T.-H., Charnock-Jones D.S., Skepper J.N., and Burton G.J. Secretion of tumour necrosis factor-a from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 164 (2004) 1049-1061
39. Tjoa M.L., Cindrova-Davies T., Spasic-Boskovic O., Bianchi D.W., and Burton G.J. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 169 (2006) 400-404
40. Cindrova-Davies T. Pre-eclampsia; from placental oxidative stress to maternal endothelial dysfunction. Placenta 23 Suppl. A (2009) S55-S65
41. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
42. Myatt L., and Cui X. Oxidative stress in the placenta. Histochem Cell Biol 122 (2004) 369-382
43. Roberts J.M., and Hubel C.A. Is oxidative stress the link in the two-stage model of pre-eclampsia?. Lancet 354 (1999) 788-789
44. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
45. Takagi Y., Nikaido T., Toki T., Kita N., Kanai M., Ashida T., et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 444 (2004) 49-55
46. Cindrova-Davies T., Yung H.W., Johns J., Spasic-Boskovic O., Korolchuk S., Jauniaux E., et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol 171 (2007) 1168-1179
47. Sahlin L., Ostlund E., Wang H., Holmgren A., and Fried G. Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction. Placenta 21 (2000) 603-609
48. Choi S.J., Oh S.Y., Kim J.H., Sadovsky Y., and Roh C.R. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia. Am J Obstet Gynecol 196 45 (2007) e1-e7
49. Vaiman D., Mondon F., Garces-Duran A., Mignot T.M., Robert B., Rebourcet R., et al. Hypoxia-activated genes from early placenta are elevated in preeclampsia, but not in intra-uterine growth retardation. BMC Genomics 6 (2005) 111
50. Sibley C.P., Turner M.A., Cetin I., Ayuk P., Boyd C.A.R., D'Souza S.W., et al. Placental phenotypes of intrauterine growth. Ped Res 58 (2005) 827-832
51. Shibata E., Hubel C.A., Powers R.W., von Versen-Hoeynck F., Gammill H., Rajakumar A., et al. Placental system A amino acid transport is reduced in pregnancies with small for gestational age (SGA) infants but not in preeclampsia with SGA infants. Placenta 29 (2008) 879-882
52. Shibata E., Rajakumar A., Powers R.W., Larkin R.W., Gilmour C., Bodnar L.M., et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 90 (2005) 4895-4903
53. Chaiworapongsa T., Espinoza J., Gotsch F., Kim Y.M., Kim G.J., Goncalves L.F., et al. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med 21 (2008) 25-40
54. Levine R.J., Thadhani R., Qian C., Lam C., Lim K.H., Yu K.F., et al. Urinary placental growth factor and risk of preeclampsia. JAMA 293 (2005) 77-85
55. Sekizawa A., Jimbo M., Saito H., Iwasaki M., Matsuoka R., Okai T., et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 188 (2003) 480-484
56. Laivuori H., Gallaher M.J., Collura L., Crombleholme W.R., Markovic N., Rajakumar A., et al. Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia. Mol Hum Reprod 12 (2006) 551-556
57. Johnson M.R., Anim-Nyame N., Johnson P., Sooranna S.R., and Steer P.J. Does endothelial cell activation occur with intrauterine growth restriction?. BJOG 109 (2002) 836-839